Imatinib (Gleevec) as a Paradigm of Targeted Cancer Therapies by Brian Druker, March 2007 - Part 1: Chronic Myeloid Leukemia (CML) and Imatinib (33:54)

December 2, 2008
5526 views
URL
Embed
Share

Please describe the reason for abuse:



Description:
Imatinib (Gleevec) has become a paradigm for targeted cancer therapies. The first part of this lecture will describe the clinical features and the... » More

Belongs to: